表 4.

BD患者血栓发生危险因素的Logistic分析结果

Logistic regression of risk factors of thrombosis in patients with BD

Items	Univariate						Multivariate
	B	SE	Z	P	OR (95%CI)		B	SE	Z	P	OR (95%CI)
OR, odds ratio; CI, confidence interval; aβ2GPI, anti-β2 glycoproteinⅠantibody; aCL, anti-cardiolipin antibody; LAC, lupus anticoagulant; HLA-B51, human leukocyte antigen-B51; AECA, anti-endothelial cell antibody; Other abbreviations as in Table 3.
Age/years	0.00	0.01	-0.29	0.770	1.00 (0.97-1.02)
ESR/(mm/h)	0.00	0.01	-0.17	0.868	1.00 (0.98-1.02)
PT/s	0.20	0.08	2.45	0.014	1.22 (1.04-1.43)		0.08	0.09	0.90	0.368	1.09 (0.90-1.31)
Fib/(mg/dL)	0.00	0.00	1.34	0.182	1.00 (1.00-1.00)
APTT/s	0.00	0.01	-0.17	0.868	1.00 (0.98-1.02)
IgA/(g/L)	0.01	0.12	-0.12	0.906	0.99 (0.78-1.25)
IgG/(g/L)	0.05	0.05	0.96	0.337	1.05 (0.95-1.17)
IgM/(g/L)	0.11	0.29	0.39	0.698	1.12 (0.63-1.99)
aβ2GPI (+)	0.25	0.65	-0.39	0.700	0.78 (0.22-2.79)
aCL (+)	2.31	1.24	1.86	0.062	10.06 (0.89-114.09)
LAC (+)	2.20	0.49	4.48	< 0.001	9.06 (3.45-23.76)		2.14	0.58	3.67	< 0.001	8.51 (2.71-26.72)
HLA-B51 (+)	0.59	0.46	1.29	0.196	1.81 (0.74-4.45)
AECA (+)	0.14	0.45	-0.31	0.760	0.87 (0.36-2.11)
Aneurysm	1.05	0.46	2.29	0.022	2.85 (1.16-7.00)		0.99	0.50	1.97	0.049	2.70 (1.01-7.24)